The global viral vector and plasmid DNA manufacturing market size is calculated at USD 8.66 billion in 2025 and is expected ...

Unity Software's Q4 results show progress amid challenges. Learn about its AI ad tech, future growth prospects, and why 2025 ...

Boehringer Ingelheim, IP Group, the UK Respiratory Gene Therapy Consortium (GTC)[1] and OXB,[2] today announce the start of LENTICLAIRTM 1, a Phase I/II trial of BI 3720931, a novel, first-in-class, ...

Paris, France, February 20, 2025 – EG 427, a biotechnology company leading the development of pinpoint genetic medicines for prevalent chronic diseases in neurology, announced today the successful ...

Telefónica España has signed an agreement with the Government of Biscay to become its technology partner and collaborate in ...

OXB announces that its proprietary lentiviral vector manufacturing technology will be used in Boehringer Ingelheim’s newly initiated LENTICLAIR ...

Apex Fusion releases the PRIME chain and the AP3X token, which combine Bitcoin's security with Ethereum's programmability.

Cisco AI Defense is purpose-built to address the security paradox AI creates with its exponential growth in enterprises ...

Trump has always been a wrecking ball, but now that he’s pummeling Big Tech’s perceived enemies, he’s become a hero to a ...

Shift Bioscience, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the establishment of a new North American team and facilities to advance development ...